Whistleblower Law Blog

As Vaccine Rollout Continues, What Whistleblower Protections Exist in Big Pharma?

April 14, 2021
The nationwide rollout of the COVID-19 vaccine has continued to gain momentum some five months after the shot first became available to limited populations. In all 50 states, everyone above the age of 16 is either already eligible to receive the shot, or will become eligible shortly. On April 3rd, more than 4 million people in...

The Criminal Antitrust Anti-Retaliation Act: An Excellent – but Flawed – Step Forward

March 24, 2021
In the wake of “fake news” and the renewed focus on the incredible power of American technology giants, monopolistic and anticompetitive behavior across industries has been thrust into the spotlight once more. Many companies have seized upon the radical transformation of the American economy brought on by the COVID-19 pandemic...

​​​​​​​Strengthened Whistleblower Provisions in the Anti-Money Laundering Act of 2020

January 21, 2021
On January 1, 2021, the U.S. Senate voted to override President Trump’s veto of the William M. Thornberry National Defense Authorization Act (“NDAA”) for Fiscal Year 2021. The NDAA, which authorizes FY2021 appropriations and sets forth policies for Department of Defense programs and activities, contains the Anti-Money...

COVID-19 Whistleblower Protections: Few Options for Workers Reporting Unsafe Working Conditions

July 24, 2020
The United States has been rocked by the COVID-19 pandemic in innumerable ways and it has had profound and ongoing impacts on workers. One of the most vexing problems arising from COVID-19 has been protecting workers who object to employers that are failing to implement meaningful safety precautions to protect their workers...

The Federal Government Is Taking Action Against COVID-19 Fraud

June 9, 2020
The federal government has responded to the coronavirus (“COVID-19”) pandemic with legislation to aid individuals and struggling businesses. One of the many laws created was the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”), a $2 trillion federal appropriation addressing the economic fallout caused by...

Veterans Affairs Case Offers Clarification on WPA Burden of Proof

May 14, 2020
In Sistek v. Dep’t of Veterans Affairs, 955 F.3d 948, 954 (Fed. Cir. 2020), the Federal Circuit clarified a federal whistleblower’s burden of proving retaliation when the discrimination he alleges is not specifically identified as a prohibited personnel action in the Whistleblower Protection Act of 1989 (“WPA”), 5 U.S.C. § 2302...

Strong Whistleblower Protections Are Vital During Covid-19

April 24, 2020
This article originally appeared in Bloomberg Law on April 24, 2020. During the coronavirus pandemic, we are now more than ever relying on our governments and health-care providers to take unprecedented action to save lives and meet new and continually evolving challenges. At the same time, we are seeing ever growing gaps in...

Virginia Takes Major Step Forward in Protecting Whistleblowers

April 17, 2020
On April 11, 2020, Virginia Governor Ralph Northam signed into law HB798 (“VA Whistleblower Protection Law”), strengthening whistleblower protections for workers in the state of Virginia.   The VA Whistleblower Protection Law amends the Code of Virginia, adding a section numbered § 40.1-27.3. to the Code’s Protection...

Renewed Importance of False Claims Act Enforcement Under the CARES Act

April 10, 2020
The False Claims Act, 31 U.S.C. § 3729 et seq. (“FCA”), is one of the federal government’s most powerful tools for recovering fraudulently obtained federal funds.  Though it has been in effect for more than 150 years, the FCA will take on renewed importance as the federal government begins to distribute more than $2...

Jury Awards Pharma Whistleblower Over $760k in Retaliation Case

March 20, 2020
A federal district court in Massachusetts recently ordered Minneapolis based Coloplast to pay over $760,000 to Plaintiff, Amy Lestage, for retaliating against her after she and others filed a whistleblower complaint against the company.   In December 2011, pharmaceutical whistleblower, Lestage, along with two former...

Pages